Position in ABBV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$275,598,978
-$70,849,212 QoQ
Shares Held
1,267,180
-16.4% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Korea Investment CORP holds $2,395,402,868 across 10 Drug Manufacturers - General names. ABBV ranks #3 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
711,353 | $654,281,148 | |
| 2 | JNJ |
Johnson & Johnson
|
1,977,874 | $483,471,520 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,267,180 | $275,598,978 | |
| 4 | AZN |
Astrazeneca PLC
|
1,345,126 | $265,285,749 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,897,151 | $228,208,293 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,132,515 | $157,838,615 | |
| 7 | AMGN |
Amgen Inc
|
395,932 | $139,308,674 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,703,989 | $103,346,932 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $275,598,978 | 1,267,180 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $346,448,190 | 1,516,251 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $358,921,731 | 1,550,150 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $252,733,324 | 1,361,563 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $281,037,556 | 1,341,340 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $235,423,712 | 1,324,838 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $268,443,055 | 1,359,343 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $213,037,273 | 1,242,055 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $259,998,009 | 1,427,776 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $236,359,004 | 1,525,192 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $216,183,059 | 1,450,309 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $181,780,949 | 1,349,224 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $231,283,640 | 1,451,237 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $240,702,257 | 1,489,402 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $207,716,817 | 1,547,700 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $235,324,826 | 1,536,464 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $226,869,054 | 1,399,476 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $155,665,182 | 1,149,669 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $115,727,898 | 1,072,846 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $114,361,815 | 1,015,286 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $107,235,847 | 990,906 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $118,198,236 | 1,103,110 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $109,900,749 | 1,254,718 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $128,578,295 | 1,309,618 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $69,811,373 | 916,280 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||